Jason Laine

Florida’s Medical Cannabis Market Shows Signs of Cooling 0
- MEDICAL MARIJUANA
- November 18, 2024
Recent data from Florida’s Office of Medical Marijuana Use reveals a significant slowdown in the state’s medical cannabis market. Patient growth has decelerated to a record low of 2.7% annually, down from 8.4% in late May. Despite an increase in dispensaries, the market is facing challenges with slowing revenue growth and increasing competition. Interestingly, unit
READ MORE
CBD Shows Promise in Reducing Fever and Inflammation, Study Finds 0
- CANNABIS OIL
- November 13, 2024
A groundbreaking study published in Progress in Neuropsychopharmacology & Biological Psychiatry reveals that cannabidiol (CBD) may effectively reduce fever and inflammation. Researchers at the University of São Paulo found that CBD lowered fever in mice by altering biological pathways related to stress and inflammation responses. The study, led by Professor Luiz Guilherme S. Branco, demonstrated
READ MORE

Medicinal Cannabis: Balancing Benefits and Risks 0
- MEDICAL MARIJUANA
- November 11, 2024
As the use of medicinal cannabis grows in Australia, healthcare professionals are calling for increased awareness and monitoring of potential side effects. Recent reports from doctors indicate a rise in psychosis cases among patients prescribed medicinal cannabis, prompting a closer look at prescription practices and patient education. While these concerns highlight the need for caution,
READ MORE
Cannabis Oil Recall Expands Across Canada Due to Intoxication Concerns 0
- CANNABIS OIL
- November 6, 2024
Health Canada has widened its recall of cannabis oils and softgels, now affecting 14 lots of products from multiple brands. The recall, which began in June, has expanded to include over 17,000 units sold across six provinces and territories between December 2022 and July 2024. The agency’s inspection revealed significant quantities of intoxicating cannabinoids HHC
READ MORE